MAPT and Alzheimer disease: In conclusion, the novel mouse model of AD featuring both Aß and tau pathologies described here provides a powerful tool for investigating the role of CRMP2 phosphorylation at S522 in Aß-induced tau pathology and its contribution to AD progression.